Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 24, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - November 24, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/24/17 - Abbott Laboratories' Trademark Application for "DIETETIC CURRENTS" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "DIETETIC CURRENTS" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona, Abbo
11/24/17 - ABPI - Budget 2017 Reaction from the UK pharmaceutical industry
The Chief Executive of the Association of the British Pharmaceutical Industry has responded to today's Budget. A further GBP3bn to prepare for Britain's departure from the European Union. Confirmation that the imminent Industrial Strategy announcements will set out the first set of sector deals that have been agreed between the government and some
11/24/17 - Acasti Pharma Clarifies Term of Proposed Strategic Partnership with Leading China Pharmaceutical Company
Laval, Quebec, CANADA- Acasti Pharma Inc., a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, today clarified the proposed term of the transaction contemplated by its recently announced non-binding term sheet with a leadi
11/24/17 - Alkermes' Corporate Presentation to be Webcast at the Jefferies 2017 London Healthcare Conference
By a News Reporter-Staff News Editor at Drug Week Alkermes plc announced that its corporate presentation will be webcast live at the Jefferies 2017 London Healthcare Conference on Wednesday, Nov. 15, 2017 at 2:40 p.m. GMT. Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of cen
11/24/17 - An Application for the Trademark "EAS PHOS FORCE" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "EAS PHOS FORCE" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe, Abb
11/24/17 - An Application for the Trademark "NURSE CURRENTS" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "NURSE CURRENTS" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona, Abbott
11/24/17 - ANI Pharmaceuticals, Inc. Stock Rating Lowered by ValuEngine [Ghana News Agency]
ValuEngine cut shares of ANI Pharmaceuticals, Inc. from a buy rating to a hold rating in a research note released on Tuesday, November 14th. Canaccord Genuity started coverage on ANI Pharmaceuticals in a report on Monday, July 31st. Finally, Zacks Investment Research upgraded ANI Pharmaceuticals from a hold rating to a buy rating and set a $71.00 p
11/24/17 - Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference
VANCOUVER, British Columbia- Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main, Aquinox President& CEO, will participate in a fireside chat presentation at the upcoming 29th Annual Piper Jaffray
11/24/17 - Arbutus Biopharma Corp. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on November 2, 2017. The SEC file number is 0001628280-17-010727.. A U.S. Securities and Exchange Commission filing is a form
11/24/17 - Arbutus Biopharma Corp. Files SEC Form 8-K, Current Report: (Nov. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on November 2, 2017. The SEC file number is 0001171843-17-006559.. A U.S. Securities and Exchange Commission filing is a form
11/24/17 - Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference
BOULDER, Colo.- Array BioPharma Inc. today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Piper Jaffray Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, devel
11/24/17 - Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017
By a News Reporter-Staff News Editor at Drug Week Aurinia Pharmaceuticals Inc., announced that it will release its third quarter 2017 financial results on Tuesday, November 14, 2017, after the market closes. The conference call and webcast is scheduled for November 14, 2017 at 4:30pm EST. The company is headquartered in Victoria, BC and focuses i
11/24/17 - Biocon launches oncologic biosimilar KRABEVA in India [All Iraq News Agency (AIN)]
Biotechnology major Biocon today said it has launched its cancer biosimilar drug KRABEVA in India. The biosimilar product will be used for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers in India, Biocon said in a filing to the BSE. Biocon CEO and Joint MD Arun Chandav
11/24/17 - Cancer Prevention Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference
TUCSON, Arizona- Cancer Prevention Pharmaceuticals, a clinical stage biotechnology company, today announced it will give a corporate presentation at the Piper Jaffray 29th Annual Healthcare Conference on November 28, 7:50 -8: 10 am ET at the Lotte New York Palace in New York City. About Cancer Prevention Pharmaceuticals, Inc.. Cancer Prevention...
11/24/17 - CLINIGEN REGISTERS GARSUN IN SOUTH AFRICA FOR THE TREATMENT OF PATIENTS WITH SEVERE MALARIA
Clinigen Group plc, the global pharmaceutical and services company, announces that it has registered Garsun in South Africa. Equity Pharmaceutical Ltd, a division of Clinigen, will be the Holder of the Certificate of Registration. Benjamin Miny, Managing Director, South Africa, Clinigen, said:' The conversion of unlicensed to licensed medicines is
11/24/17 - Colorado BioScience Association to Honor Life Science Industry Innovation, Leadership at 2017 Awards Dinner
By a News Reporter-Staff News Editor at Drug Week Colorado BioScience Association highlights a banner year marked by acquisitions, investments, discoveries and partnerships during its 14th Annual Awards Dinner on Thursday, November 9 in downtown Denver at the Hyatt Regency. As a highlight of the event, Colorado BioScience Association will announc
11/24/17 - Cti Biopharma Corp. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on November 6, 2017. The SEC file number is 0000891293-17-000114.. A U.S. Securities and Exchange Commission filing is a formal d
11/24/17 - Cti Biopharma Corp. Files SEC Form 8-K, Current Report: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on November 6, 2017. The SEC file number is 0000891293-17-000116.. A U.S. Securities and Exchange Commission filing is a formal d
11/24/17 - Cti Biopharma Corp. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on November 7, 2017. The SEC file number is 0001193125-17-334568.. A U.S. Securities and Exchange Commission filing is a formal d
11/24/17 - Cumberland Pharmaceuticals Assigned Patent for Stabilized Statin Formulations
Cumberland Pharmaceuticals, Nashville, Tennessee, has been assigned a patent developed by two co-inventors for stabilized statin formulations. The co-inventors are Leo Pavliv, Cary, North Carolina, and Andrew Vila, Nashville, Tennessee. Written by Kusum Sangma; edited by Sudarshan Harpal.
11/24/17 - Data on Drug Conjugates Described by Researchers at University of Queensland (Polymer-drug conjugates as inhalable drug delivery systems: A review)
According to news reporting originating in St. Lucia, Australia, by NewsRx journalists, research stated, "Accelerating interest by the pharmaceutical industry in the identification and development of less invasive routes of nanomedicine administration, coupled with defined efforts to improve the treatment of respiratory diseases through inhaled dru
11/24/17 - Data on Drug Delivery Systems Reported by Researchers at French National Institute of Health and Medical Research (INSERM) (Assessment of dually...
Data on Drug Delivery Systems Reported by Researchers at French National Institute of Health and Medical Research. According to news reporting originating from Paris, France, by NewsRx correspondents, research stated, "Uptake and passage of nanocarriers through the placenta are critical information to develop new therapeutic approaches during...
11/24/17 - Data on Pharmaceutical Research Discussed by Researchers at University of Veterinary and Pharmaceutical Sciences (Factor analysis in optimization of...
Data on Pharmaceutical Research Discussed by Researchers at University of Veterinary and Pharmaceutical Sciences. By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies- Pharmaceutical Research are discussed in a new report. Our news journalists obtained a quote from the research from the University of Veterina
11/24/17 - Debiopharm International SA Launches Clinical Trials Website for Patients - patients.debiopharm.com
Lausanne, Switzerland- Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, announced today the launch of its new clinical trials website patients.debiopharm.com. The website provides patients and their caregivers with helpful information on Debiopharm's clinical trials and studies.
11/24/17 - DIAGNOS Announces a Second Contract for Its Cardio Platform with a Multinational Pharmaceutical Company and the Resignation of a Director
Brossard, Quebec, Canada- DIAGNOS Inc., a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence, announces today a second Cardio project with one of the largest pharmaceutical company in the world to monitor hypertensive patients under treatment and the resignation of Dr.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415